cagrilintide tirzepatide combination study Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 Cagrilintide and semaglutide together drive
Description
Gastroenterology 155, 10041007

Not during reconstitution, but during the drawing process

10.1007/s00109-008-0359-6 54 Teixeira-ClercF.JulienB.GrenardP.Van NhieuJ

5 - 9, Journal articles | 2009 Joshua AM
